SSRIs recommended as first-line in social anxiety disorder Newsletter Article 13 February 2013 Pages: 2 - 2
Updated guidelines to breathe new life into CHD prevention Newsletter Article 13 February 2013 Pages: 2 - 2
Growing role for pharmacoeconomics in R&D decision-making Mark Greener Newsletter Article 13 February 2013 Pages: 3 - 4
Nurse case managers help with glycaemic control in diabetes Newsletter Article 13 February 2013 Pages: 6 - 6
Use evidence-based medicine to identify primary-care indicators Newsletter Article 13 February 2013 Pages: 7 - 7
Pramipexole favourable option in Parkinson’s disease Newsletter Article 13 February 2013 Pages: 8 - 8
‘Neoral’ superior to ‘Sandimmune’ in liver transplantation Newsletter Article 13 February 2013 Pages: 8 - 8
Patients with incontinence value a reduction in symptoms Newsletter Article 13 February 2013 Pages: 10 - 10
Salmeterol powder improves status in children with asthma Newsletter Article 13 February 2013 Pages: 10 - 11
UK authorities not funding paclitaxel for ovarian cancer Newsletter Article 13 February 2013 Pages: 11 - 11
NZ drug subsidy agency sees ‘real pay-offs’ in last 5 years Newsletter Article 13 February 2013 Pages: 11 - 11
GPs and drug industry come to agreement with French government Newsletter Article 13 February 2013 Pages: 12 - 12